The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 1, Pages 94-106
Publisher
Springer Nature
Online
2013-11-06
DOI
10.1038/bjc.2013.692
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model
- (2013) K. C. Sia et al. MOLECULAR CANCER THERAPEUTICS
- Multimechanistic Tumor Targeted Oncolytic Virus Overcomes Resistance in Brain Tumors
- (2012) Kaoru Tamura et al. MOLECULAR THERAPY
- Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation
- (2011) S Yamada et al. CANCER GENE THERAPY
- Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene
- (2011) X Cao et al. GENE THERAPY
- Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
- (2011) S J Advani et al. GENE THERAPY
- Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging
- (2011) K C Sia et al. GENE THERAPY
- Strategies to Enhance Viral Penetration of Solid Tumors
- (2011) Elspeth Smith et al. HUMAN GENE THERAPY
- Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-expressing Oncolytic Virus
- (2011) Ji Young Yoo et al. MOLECULAR THERAPY
- Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma
- (2011) Wei Zhang et al. MOLECULAR THERAPY
- Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
- (2010) S L Longo et al. CANCER GENE THERAPY
- OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
- (2010) Howard L Kaufman et al. Future Oncology
- Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection
- (2010) C-S Hong et al. GENE THERAPY
- Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells
- (2010) Kian Chuan Sia et al. JOURNAL OF GENE MEDICINE
- FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors
- (2010) Ivy A Ho et al. Molecular Cancer
- Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells
- (2009) B J Passer et al. CANCER GENE THERAPY
- Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
- (2009) I-K Choi et al. GENE THERAPY
- Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect
- (2009) D Kolodkin-Gal et al. GENE THERAPY
- Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
- (2009) Jayson Hardcastle et al. MOLECULAR THERAPY
- Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
- (2008) S. Ganesh et al. CLINICAL CANCER RESEARCH
- Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2
- (2008) L. Menotti et al. JOURNAL OF VIROLOGY
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started